Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes (Q37038686)

From Wikidata
Jump to navigation Jump to search
scientific article published on 16 October 2008
edit
Language Label Description Also known as
English
Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes
scientific article published on 16 October 2008

    Statements

    Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes (English)
    Golareh Habibi
    Samuel Leung
    Jennifer H Law
    Karen Gelmon
    Hamid Masoudi
    Dmitry Turbin
    Michael Pollak
    Torsten O Nielsen
    David Huntsman
    Sandra E Dunn
    16 October 2008

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit